The Exchange had sought clarification from Lotus Eye Hospital and Institute Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: The response of the Company is enclosed.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE had asked Lotus Eye Hospital and Institute Limited to clarify certain aspects of its financial results for the quarter ended June 30, 2025, under Regulation 33 of the SEBI Listing Regulations, 2015. The company has submitted its response to the exchange, which is enclosed with this filing. The actual clarification contents were not included in the headline itself, so specific figures and details are not available here. Investors would need to refer to the enclosed response document for the full substance of the clarification.
The exchange seeking a clarification does not itself imply any negative finding, but it signals that the regulator wanted more information on the company's results. Shareholders should review the enclosed clarification to understand what was asked and answered, as it may contain material details about the company's financial performance or disclosures.